Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil Add-on to Bosentan in PAH
NCT00323297Phase 4Completed
- Sponsor
- Viatris
- Start
- Sep 2006
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 4 trial of sildenafil in pulmonary arterial hypertension (PAH), sponsored by Viatris. Started Sep 2006; status: completed.
02
Drugs
sildenafil
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00323297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00323297.